{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:51:49Z","timestamp":1787021509156,"version":"build-2736575974"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007675","name":"International Center for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","award":["ICGEB CRP\/SVK24-02"],"award-info":[{"award-number":["ICGEB CRP\/SVK24-02"]}],"id":[{"id":"10.13039\/100007675","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007675","name":"International Center for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","award":["ICGEB CRP\/SVK24-02"],"award-info":[{"award-number":["ICGEB CRP\/SVK24-02"]}],"id":[{"id":"10.13039\/100007675","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-22-0084"],"award-info":[{"award-number":["APVV-22-0084"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-22-0084"],"award-info":[{"award-number":["APVV-22-0084"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-23-0348"],"award-info":[{"award-number":["APVV-23-0348"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-23-0348"],"award-info":[{"award-number":["APVV-23-0348"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-23-0348"],"award-info":[{"award-number":["APVV-23-0348"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-23-0348"],"award-info":[{"award-number":["APVV-23-0348"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-22-0084"],"award-info":[{"award-number":["APVV-22-0084"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018225","name":"EuroNanoMed III","doi-asserted-by":"publisher","award":["EURONANOMED2021-105"],"award-info":[{"award-number":["EURONANOMED2021-105"]}],"id":[{"id":"10.13039\/100018225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018225","name":"EuroNanoMed III","doi-asserted-by":"publisher","award":["EURONANOMED2021-105"],"award-info":[{"award-number":["EURONANOMED2021-105"]}],"id":[{"id":"10.13039\/100018225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018225","name":"EuroNanoMed III","doi-asserted-by":"publisher","award":["EURONANOMED2021-105"],"award-info":[{"award-number":["EURONANOMED2021-105"]}],"id":[{"id":"10.13039\/100018225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018225","name":"EuroNanoMed III","doi-asserted-by":"publisher","award":["EURONANOMED2021-105"],"award-info":[{"award-number":["EURONANOMED2021-105"]}],"id":[{"id":"10.13039\/100018225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","award":["VEGA1\/0381\/23"],"award-info":[{"award-number":["VEGA1\/0381\/23"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-19248-4","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T09:31:02Z","timestamp":1760088662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nanobody conjugated with dendrimer nanoparticles effectively neutralizes tick-borne encephalitis virus"],"prefix":"10.1038","volume":"15","author":[{"given":"Jana","family":"Jozefiakov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amod","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Dhumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1d\u00e1m","family":"Kev\u00e9ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Nov\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Ko\u010di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juraj","family":"Ko\u010di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangesh","family":"Bhide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"19248_CR1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41573-022-00495-3","volume":"21","author":"G Pantaleo","year":"2022","unstructured":"Pantaleo, G., Correia, B., Fenwick, C., Joo, V.S. & Perez, L. Antibodies to combat viral infections: development strategies and progress. Nature Reviews Drug Discovery 21, 676\u2013696 (2022).","journal-title":"Nature Reviews Drug Discovery"},{"key":"19248_CR2","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1111\/febs.15515","volume":"288","author":"S Muyldermans","year":"2021","unstructured":"Muyldermans, S. A guide to: generation and design of nanobodies. FEBS J 288, 2084\u20132102 (2021).","journal-title":"FEBS J"},{"key":"19248_CR3","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.drudis.2016.04.003","volume":"21","author":"S Steeland","year":"2016","unstructured":"Steeland, S., Vandenbroucke, R.E. & Libert, C. Nanobodies as therapeutics: big opportunities for small antibodies. Drug Discov Today 21, 1076\u20131113 (2016).","journal-title":"Drug Discov Today"},{"key":"19248_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.joca.2018.02.381","volume":"26","author":"J Pereira","year":"2018","unstructured":"Pereira, J., et al. Pharmacokinetic and pharmacodynamic modelling of the novel anti-ADAMTS-5 nanobody M6495 using the neo-epitope ARGS as a biomarker. Osteoarthritis and Cartilage 26, S176 (2018).","journal-title":"Osteoarthritis and Cartilage"},{"key":"19248_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa1806311","volume":"380","author":"M Scully","year":"2019","unstructured":"Scully, M., et al. Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura. N Engl J Med 380, 335\u2013346 (2019).","journal-title":"N Engl J Med"},{"key":"19248_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3390\/ijms19020403","volume":"19","author":"S De Munter","year":"2018","unstructured":"De Munter, S. et al. Nanobody based dual specific CARs. Int. J. Mol. Sci. 19, 403 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"19248_CR7","first-page":"240-+","volume":"15","author":"A Muruganandam","year":"2001","unstructured":"Muruganandam, A., Tanha, J., Narang, S. & Stanimirovic, D. Selection of phage-displayed Llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium. Faseb J 15, 240-+ (2001).","journal-title":"Faseb J"},{"key":"19248_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.molimm.2015.04.001","volume":"67","author":"AC Freise","year":"2015","unstructured":"Freise, A.C. & Wu, A.M. In vivo imaging with antibodies and engineered fragments. Mol Immunol 67, 142\u2013152 (2015).","journal-title":"Mol Immunol"},{"key":"19248_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ajhg.2013.11.009","volume":"94","author":"M Peyrard-Janvid","year":"2014","unstructured":"Peyrard-Janvid, M., et al. Dominant mutations in GRHL3 cause Van der woude syndrome and disrupt oral periderm development. Am J Hum Genet 94, 23\u201332 (2014).","journal-title":"Am J Hum Genet"},{"key":"19248_CR10","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1021\/bc300066a","volume":"23","author":"Y Vugmeyster","year":"2012","unstructured":"Vugmeyster, Y., et al. Pharmacokinetic, biodistribution, and biophysical profiles of TNF nanobodies conjugated to linear or branched Poly(ethylene glycol). Bioconjugate Chemistry 23, 1452\u20131462 (2012).","journal-title":"Bioconjugate Chemistry"},{"key":"19248_CR11","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.1096\/fj.14-253369","volume":"28","author":"GK Farrington","year":"2014","unstructured":"Farrington, G.K., et al. A novel platform for engineering blood-brain barrier-crossing bispecific biologics. Faseb J 28, 4764\u20134778 (2014).","journal-title":"Faseb J"},{"key":"19248_CR12","doi-asserted-by":"publisher","first-page":"13272","DOI":"10.1096\/fj.202000610RR","volume":"34","author":"D Sehlin","year":"2020","unstructured":"Sehlin, D., et al. Brain delivery of biologics using a cross-species reactive transferrin receptor 1 VNAR shuttle. Faseb J 34, 13272\u201313283 (2020).","journal-title":"Faseb J"},{"key":"19248_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"C Saraiva","year":"2016","unstructured":"Saraiva, C., et al. Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases. J Control Release 235, 34\u201347 (2016).","journal-title":"J Control Release"},{"key":"19248_CR14","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/nbt1171","volume":"23","author":"CC Lee","year":"2005","unstructured":"Lee, C.C., MacKay, J.A., Fr\u00e9chet, J.M. & Szoka, F.C. Designing dendrimers for biological applications. Nat Biotechnol 23, 1517\u20131526 (2005).","journal-title":"Nat Biotechnol"},{"key":"19248_CR15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/joim.12280","volume":"276","author":"RM Kannan","year":"2014","unstructured":"Kannan, R.M., Nance, E., Kannan, S. & Tomalia, D.A. Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications. J Intern Med 276, 579\u2013617 (2014).","journal-title":"J Intern Med"},{"key":"19248_CR16","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41551-017-0136-3","volume":"1","author":"Z Lyu","year":"2017","unstructured":"Lyu, Z. & Peng, L. Potent drugless dendrimers. Nature Biomedical Engineering 1, 686\u2013688 (2017).","journal-title":"Nature Biomedical Engineering"},{"key":"19248_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S1359-6446(01)01757-3","volume":"6","author":"R Esfand","year":"2001","unstructured":"Esfand, R. & Tomalia, D.A. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discovery Today 6, 427\u2013436 (2001).","journal-title":"Drug Discovery Today"},{"key":"19248_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1039\/9781788012904-00085","volume-title":"Dendrimer Chemistry: Synthetic Approaches Towards Complex Architectures","author":"Z Lyu","year":"2020","unstructured":"Lyu, Z. et al. Poly(amidoamine) (PAMAM) dendrimers: synthesis and biological applications. in Dendrimer Chemistry: Synthetic Approaches Towards Complex Architectures (eds Malkoch, M. & Garc\u00eda Gallego, S.) 85\u2013113 (The Royal Society of Chemistry, 2020)."},{"key":"19248_CR19","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/ijms18030628","volume":"18","author":"B Srinageshwar","year":"2017","unstructured":"Srinageshwar, B. et al. PAMAM dendrimers cross the blood-brain barrier when administered through the carotid artery in C57BL\/6J mice. Int. J. Mol. Sci. 18, 628 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"19248_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.7150\/ntno.38954","volume":"3","author":"C Liu","year":"2019","unstructured":"Liu, C., et al. Enhanced blood-brain-barrier penetrability and tumor-targeting efficiency by peptide-functionalized poly(amidoamine) dendrimer for the therapy of gliomas. Nanotheranostics 3, 311\u2013330 (2019).","journal-title":"Nanotheranostics"},{"key":"19248_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jconrel.2014.06.006","volume":"188","author":"S Somani","year":"2014","unstructured":"Somani, S., Blatchford, D.R., Millington, O., Stevenson, M.L. & Duf\u00e8s, C. Transferrin-bearing polypropylenimine dendrimer for targeted gene delivery to the brain. J Control Release 188, 78\u201386 (2014).","journal-title":"J Control Release"},{"key":"19248_CR22","doi-asserted-by":"publisher","first-page":"e2322403121","DOI":"10.1073\/pnas.2322403121","volume":"121","author":"Z Lyu","year":"2024","unstructured":"Lyu, Z., et al. Self-assembling dendrimer nanosystems for specific fluorine magnetic resonance imaging and effective theranostic treatment of tumors. Proc Natl Acad Sci U S A 121, e2322403121 (2024).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"19248_CR23","doi-asserted-by":"crossref","unstructured":"Jiang, Y., et al. Dendrimer nanosystems for adaptive tumor-assisted drug delivery via extracellular vesicle hijacking. Proceedings of the National Academy of Sciences 120, e2215308120 (2023).","DOI":"10.1073\/pnas.2215308120"},{"key":"19248_CR24","doi-asserted-by":"crossref","unstructured":"Wei, T., et al. Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance. Proceedings of the National Academy of Sciences 112, 2978\u20132983 (2015).","DOI":"10.1073\/pnas.1418494112"},{"key":"19248_CR25","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1021\/acs.accounts.0c00589","volume":"53","author":"Z Lyu","year":"2020","unstructured":"Lyu, Z., Ding, L., Tintaru, A. & Peng, L. Self-assembling supramolecular dendrimers for biomedical applications: lessons learned from Poly (amidoamine) dendrimers. Accounts of Chemical Research 53, 2936\u20132949 (2020).","journal-title":"Accounts of Chemical Research"},{"key":"19248_CR26","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1021\/accountsmr.1c00272","volume":"3","author":"J Chen","year":"2022","unstructured":"Chen, J., Zhu, D., Liu, X. & Peng, L. Amphiphilic dendrimer vectors for RNA delivery: State-of-the-Art and future perspective. Accounts of Materials Research 3, 484\u2013497 (2022).","journal-title":"Accounts of Materials Research"},{"key":"19248_CR27","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3390\/pharmaceutics14040770","volume":"14","author":"AC Burdu\u0219el","year":"2022","unstructured":"Burdu\u0219el, A. C., Gherasim, O., Andronescu, E., Grumezescu, A. M. & Ficai, A. Inorganic nanoparticles in bone healing applications. Pharmaceutics 14, 770 (2022).","journal-title":"Pharmaceutics"},{"key":"19248_CR28","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1039\/C1NR11188D","volume":"4","author":"YC Yeh","year":"2012","unstructured":"Yeh, Y.C., Creran, B. & Rotello, V.M. Gold nanoparticles: preparation, properties, and applications in bionanotechnology. Nanoscale 4, 1871\u20131880 (2012).","journal-title":"Nanoscale"},{"key":"19248_CR29","unstructured":"Cytodiagnostics. NHS-Activated Gold Nanoparticle Conjugation Kit product data sheet https:\/\/www.cytodiagnostics.com\/collections\/nhs-activated-gold-nanoparticles\/products\/20nm-nhs-activated-gold-nanoparticle-conjugation-kit-10-reactions?_pos=10&_sid=382575595&_ss=r&variant=40539148451914."},{"key":"19248_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-015-0133-1","volume":"13","author":"H Sela","year":"2015","unstructured":"Sela, H., et al. Spontaneous penetration of gold nanoparticles through the blood brain barrier (BBB). Journal of Nanobiotechnology 13, 71 (2015).","journal-title":"Journal of Nanobiotechnology"},{"key":"19248_CR31","doi-asserted-by":"crossref","unstructured":"Pulkkinen, L.I.A., Butcher, S.J. & Anastasina, M. Tick-Borne Encephalitis Virus: A Structural View. Viruses 10(2018).","DOI":"10.3390\/v10070350"},{"key":"19248_CR32","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/v9110338","volume":"9","author":"X Zhang","year":"2017","unstructured":"Zhang, X. et al. Structures and functions of the envelope glycoprotein in flavivirus infections. Viruses 9, 338 (2017).","journal-title":"Viruses"},{"key":"19248_CR33","doi-asserted-by":"publisher","first-page":"8863","DOI":"10.1038\/s41598-022-13043-1","volume":"12","author":"K Bhide","year":"2022","unstructured":"Bhide, K., et al. Signaling events evoked by domain III of envelop glycoprotein of tick-borne encephalitis virus and West nile virus in human brain microvascular endothelial cells. Sci Rep-Uk 12, 8863 (2022).","journal-title":"Sci Rep-Uk"},{"key":"19248_CR34","doi-asserted-by":"publisher","first-page":"e20210236","DOI":"10.1084\/jem.20210236","volume":"218","author":"M Agudelo","year":"2021","unstructured":"Agudelo, M. et al. Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease. J. Exp. Med. 218, e20210236 (2021).","journal-title":"J. Exp. Med."},{"key":"19248_CR35","doi-asserted-by":"publisher","first-page":"11435","DOI":"10.1038\/s41598-025-95449-1","volume":"15","author":"P Petrou\u0161kov\u00e1","year":"2025","unstructured":"Petrou\u0161kov\u00e1, P., et al. Peptides developed against receptor binding sites of the E glycoprotein neutralize tick-borne encephalitis virus. Sci Rep 15, 11435 (2025).","journal-title":"Sci Rep"},{"key":"19248_CR36","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1016\/j.vaccine.2020.04.051","volume":"38","author":"A Matveev","year":"2020","unstructured":"Matveev, A., et al. Characterization of neutralizing monoclonal antibody against tick-borne encephalitis virus in vivo. Vaccine 38, 4309\u20134315 (2020).","journal-title":"Vaccine"},{"key":"19248_CR37","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s41467-018-02882-0","volume":"9","author":"T F\u00fczik","year":"2018","unstructured":"F\u00fczik, T., et al. Structure of tick-borne encephalitis virus and its neutralization by a monoclonal antibody. Nature Communications 9, 436 (2018).","journal-title":"Nature Communications"},{"key":"19248_CR38","doi-asserted-by":"publisher","first-page":"20131","DOI":"10.1038\/s41598-021-99696-w","volume":"11","author":"P Mertinkov\u00e1","year":"2021","unstructured":"Mertinkov\u00e1, P. et al. Development of peptides targeting receptor binding site of the envelope glycoprotein to contain the West nile virus infection. Sci. Rep. 11, 20131 (2021).","journal-title":"Sci. Rep."},{"key":"19248_CR39","doi-asserted-by":"crossref","unstructured":"de la Guardia, C., Quijada, M. & Lleonart, R. Phage-Displayed Peptides Selected to Bind Envelope Glycoprotein Show Antiviral Activity against Dengue Virus Serotype 2. Adv Virol 2017, 1827341 (2017).","DOI":"10.1155\/2017\/1827341"},{"key":"19248_CR40","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1128\/JVI.01840-06","volume":"81","author":"F Bai","year":"2007","unstructured":"Bai, F., et al. Antiviral peptides targeting the West nile virus envelope protein. J Virol 81, 2047\u20132055 (2007).","journal-title":"J Virol"},{"key":"19248_CR41","doi-asserted-by":"publisher","first-page":"104673","DOI":"10.1016\/j.antiviral.2019.104673","volume":"174","author":"J Wei","year":"2020","unstructured":"Wei, J., et al. Antiviral activity of phage display-selected peptides against Japanese encephalitis virus infection in vitro and in vivo. Antiviral Res 174, 104673 (2020).","journal-title":"Antiviral Res"},{"key":"19248_CR42","first-page":"712","volume":"14","author":"S Habib","year":"2022","unstructured":"Habib, S. & Singh, M. Angiopep-2-Modified nanoparticles for Brain-Directed delivery of therapeutics: A review. Polymers\u00a0(Basel) 14, 712 (2022).","journal-title":"Polymers\u00a0(Basel)"},{"key":"19248_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.antiviral.2019.01.014","volume":"164","author":"D Ruzek","year":"2019","unstructured":"Ruzek, D., et al. Tick-borne encephalitis in Europe and russia: review of pathogenesis, clinical features, therapy, and vaccines. Antiviral Res 164, 23\u201351 (2019).","journal-title":"Antiviral Res"},{"key":"19248_CR44","doi-asserted-by":"publisher","first-page":"7769","DOI":"10.1128\/JVI.75.16.7769-7773.2001","volume":"75","author":"WD Crill","year":"2001","unstructured":"Crill, W.D. & Roehrig, J.T. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol 75, 7769\u20137773 (2001).","journal-title":"J Virol"},{"key":"19248_CR45","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/v3020160","volume":"3","author":"JM Smit","year":"2011","unstructured":"Smit, J.M., Moesker, B., Rodenhuis-Zybert, I. & Wilschut, J. Flavivirus cell entry and membrane fusion. Viruses 3, 160\u2013171 (2011).","journal-title":"Viruses"},{"key":"19248_CR46","first-page":"56","volume":"26","author":"L Comor","year":"2016","unstructured":"Comor, L., et al. Preh\u013eady Nanoprotil\u00e1tky a Ich Vyu\u017eitie v medic\u00edne a V\u00fdskume (Nanobodies and their application in medicine and research). Slovensk\u00fd Lek\u00e1r 26, 56\u201364 (2016).","journal-title":"Slovensk\u00fd Lek\u00e1r"},{"key":"19248_CR47","doi-asserted-by":"crossref","unstructured":"Jovcevska, I. & Muyldermans, S. The Therapeutic Potential of Nanobodies. BioDrugs 34, 11\u201326 (2020).","DOI":"10.1007\/s40259-019-00392-z"},{"key":"19248_CR48","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1006\/jmbi.1994.1735","volume":"244","author":"EV Meulemans","year":"1994","unstructured":"Meulemans, E.V., Slobbe, R., Wasterval, P., Ramaekers, F.C.S. & van Eys, G.J.J.M. Selection of Phage-displayed antibodies specific for a cytoskeletal antigen by competitive elution with a monoclonal antibody. Journal of Molecular Biology 244, 353\u2013360 (1994).","journal-title":"Journal of Molecular Biology"},{"key":"19248_CR49","doi-asserted-by":"publisher","first-page":"801466","DOI":"10.3389\/fmicb.2022.801466","volume":"13","author":"J Hruskovicova","year":"2022","unstructured":"Hruskovicova, J., et al. Engineering the single domain antibodies targeting receptor binding motifs within the domain III of West nile virus envelope glycoprotein. Front Microbiol 13, 801466 (2022).","journal-title":"Front Microbiol"},{"key":"19248_CR50","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.virol.2017.04.012","volume":"507","author":"M Palus","year":"2017","unstructured":"Palus, M., et al. Tick-borne encephalitis virus infects human brain microvascular endothelial cells without compromising blood-brain barrier integrity. Virology 507, 110\u2013122 (2017).","journal-title":"Virology"},{"key":"19248_CR51","doi-asserted-by":"crossref","unstructured":"Bhowmik, A., Khan, R. & Ghosh, M.K. Blood brain barrier: a challenge for effectual therapy of brain tumors. Biomed Res Int 2015, 320941 (2015).","DOI":"10.1155\/2015\/320941"},{"key":"19248_CR52","doi-asserted-by":"crossref","unstructured":"Ruiz-L\u00f3pez, E. & Schuhmacher, A.J. Transportation of Single-Domain Antibodies through the Blood-Brain Barrier. Biomolecules 11(2021).","DOI":"10.3390\/biom11081131"},{"key":"19248_CR53","doi-asserted-by":"publisher","first-page":"104753","DOI":"10.1016\/j.phrs.2020.104753","volume":"156","author":"M Norouzi","year":"2020","unstructured":"Norouzi, M. Gold nanoparticles in glioma theranostics. Pharmacol Res 156, 104753 (2020).","journal-title":"Pharmacol Res"},{"key":"19248_CR54","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2147\/IJN.S195333","volume":"14","author":"R Wahab","year":"2019","unstructured":"Wahab, R., et al. Gold quantum Dots impair the tumorigenic potential of glioma stem-like cells via \u03b2-catenin downregulation in vitro. Int J Nanomedicine 14, 1131\u20131148 (2019).","journal-title":"Int J Nanomedicine"},{"key":"19248_CR55","first-page":"1075","volume":"15","author":"H Gaitsch","year":"2023","unstructured":"Gaitsch, H., Hersh, A. M., Alomari, S. & Tyler, B. M. Dendrimer technology in glioma: Functional design and potential applications. Cancers\u00a0(Basel) 15, 1075 (2023).","journal-title":"Cancers\u00a0(Basel)"},{"key":"19248_CR56","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.colsurfb.2016.08.002","volume":"147","author":"Y Jiang","year":"2016","unstructured":"Jiang, Y., et al. PEGylated polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma. Colloids and Surfaces B: Biointerfaces 147, 242\u2013249 (2016).","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"key":"19248_CR57","unstructured":"ISO10993-5:2009(E). International standard for Biological evaluation of medical devices, available online https:\/\/www.iso.org\/standard\/36406.html. (2009)."},{"key":"19248_CR58","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/jps.20627","volume":"95","author":"K Amin","year":"2006","unstructured":"Amin, K. & Dannenfelser, R.M. In vitro hemolysis: guidance for the pharmaceutical scientist. J Pharm Sci 95, 1173\u20131176 (2006).","journal-title":"J Pharm Sci"},{"key":"19248_CR59","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.addr.2005.09.019","volume":"57","author":"R Duncan","year":"2005","unstructured":"Duncan, R. & Izzo, L. Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 57, 2215\u20132237 (2005).","journal-title":"Adv Drug Deliv Rev"},{"key":"19248_CR60","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/biom9120790","volume":"9","author":"Y Zhu","year":"2019","unstructured":"Zhu, Y., Liu, C. & Pang, Z. Dendrimer-Based drug delivery systems for brain targeting. Biomolecules 9, 790 (2019).","journal-title":"Biomolecules"},{"key":"19248_CR61","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.3390\/molecules26195960","volume":"26","author":"E Paradowska","year":"2021","unstructured":"Paradowska, E. et al. Antiviral effect of nonfunctionalized gold nanoparticles against herpes simplex virus Type-1 (HSV-1) and possible contribution of Near-Field interaction mechanism. Molecules 26, 5960 (2021).","journal-title":"Molecules"},{"key":"19248_CR62","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1016\/j.apsb.2021.04.020","volume":"11","author":"L Cheng","year":"2021","unstructured":"Cheng, L., et al. Bioresponsive micro-to-nano albumin-based systems for targeted drug delivery against complex fungal infections. Acta Pharmaceutica Sinica B 11, 3220\u20133230 (2021).","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"19248_CR63","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jconrel.2020.05.048","volume":"324","author":"S Woods","year":"2020","unstructured":"Woods, S., et al. Glucosamine-NISV delivers antibody across the blood-brain barrier: optimization for treatment of encephalitic viruses. Journal of Controlled Release 324, 644\u2013656 (2020).","journal-title":"Journal of Controlled Release"},{"key":"19248_CR64","doi-asserted-by":"publisher","first-page":"23709","DOI":"10.1039\/D0NR04035E","volume":"12","author":"S-S Zhang","year":"2020","unstructured":"Zhang, S.-S., et al. A combination of receptor mediated transcytosis and photothermal effect promotes BBB permeability and the treatment of meningitis using Itraconazole. Nanoscale 12, 23709\u201323720 (2020).","journal-title":"Nanoscale"},{"key":"19248_CR65","doi-asserted-by":"publisher","first-page":"723727","DOI":"10.3389\/fphar.2021.723727","volume":"12","author":"P Thammasit","year":"2021","unstructured":"Thammasit, P., et al. Targeted Propolis-Loaded Poly (Butyl) cyanoacrylate nanoparticles: an alternative drug delivery tool for the treatment of Cryptococcal meningitis. Front Pharmacol 12, 723727 (2021).","journal-title":"Front Pharmacol"},{"key":"19248_CR66","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1080\/10717544.2018.1486473","volume":"25","author":"W Hong","year":"2018","unstructured":"Hong, W., et al. Brain-targeted delivery of pegylated nano-bacitracin A against Penicillin-sensitive and -resistant Pneumococcal meningitis: formulated with RVG29 and Pluronic\u00ae P85 unimers. Drug Delivery 25, 1886\u20131897 (2018).","journal-title":"Drug Delivery"},{"key":"19248_CR67","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1021\/acs.nanolett.1c03514","volume":"22","author":"W Wei","year":"2022","unstructured":"Wei, W., et al. A nanodrug coated with membrane from brain microvascular endothelial cells protects against experimental cerebral malaria. Nano Lett 22, 211\u2013219 (2022).","journal-title":"Nano Lett"},{"key":"19248_CR68","doi-asserted-by":"publisher","first-page":"15741","DOI":"10.1021\/acsnano.0c09553","volume":"15","author":"B Surnar","year":"2021","unstructured":"Surnar, B., et al. Brain-Accumulating nanoparticles for assisting astrocytes to reduce human immunodeficiency virus and drug Abuse-Induced neuroinflammation and oxidative stress. ACS Nano 15, 15741\u201315753 (2021).","journal-title":"ACS Nano"},{"key":"19248_CR69","doi-asserted-by":"publisher","first-page":"5044","DOI":"10.2174\/0929867311209025044","volume":"19","author":"V Briz","year":"2012","unstructured":"Briz, V., et al. Validation of a generation 4 phosphorus-containing polycationic dendrimer for gene delivery against HIV-1. Curr Med Chem 19, 5044\u20135051 (2012).","journal-title":"Curr Med Chem"},{"key":"19248_CR70","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jconrel.2014.12.042","volume":"200","author":"MJ Serram\u00eda","year":"2015","unstructured":"Serram\u00eda, M.J., et al. In vivo delivery of SiRNA to the brain by carbosilane dendrimer. J Control Release 200, 60\u201370 (2015).","journal-title":"J Control Release"},{"key":"19248_CR71","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2174\/2211738506666180209095710","volume":"6","author":"M Saravanan","year":"2018","unstructured":"Saravanan, M., et al. Nano-Medicine as a newly emerging approach to combat human immunodeficiency virus (HIV). Pharm Nanotechnol 6, 17\u201327 (2018).","journal-title":"Pharm Nanotechnol"},{"key":"19248_CR72","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3390\/antiox12020393","volume":"12","author":"T Akanchise","year":"2023","unstructured":"Akanchise, T. & Angelova, A. Potential of Nano-Antioxidants and nanomedicine for recovery from neurological disorders linked to long COVID syndrome. Antioxidants\u00a0(Basel) 12, 393 (2023).","journal-title":"Antioxidants\u00a0(Basel)"},{"key":"19248_CR73","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.3390\/v13081656","volume":"13","author":"JRA Paull","year":"2021","unstructured":"Paull, J. R. A. et al. Protective effects of astodrimer sodium 1% nasal spray formulation against SARS-CoV-2 nasal challenge in K18-hACE2 mice. Viruses 13, 1656 (2021).","journal-title":"Viruses"},{"key":"19248_CR74","doi-asserted-by":"publisher","first-page":"e892","DOI":"10.1371\/journal.pntd.0000892","volume":"4","author":"A Nazmi","year":"2010","unstructured":"Nazmi, A., Dutta, K. & Basu, A. Antiviral and neuroprotective role of octaguanidinium dendrimer-conjugated morpholino oligomers in Japanese encephalitis. PLoS Negl Trop Dis 4, e892 (2010).","journal-title":"PLoS Negl Trop Dis"},{"key":"19248_CR75","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.3390\/v14122673","volume":"14","author":"\u00c1 Kev\u00e9ly","year":"2022","unstructured":"Kev\u00e9ly, \u00c1., et al. Fitness of mCherry reporter tick-Borne encephalitis virus in tick experimental models. Viruses 14, 2673 (2022).","journal-title":"Viruses"},{"key":"19248_CR76","doi-asserted-by":"publisher","first-page":"9286","DOI":"10.1039\/D2NR02305A","volume":"14","author":"D Dhumal","year":"2022","unstructured":"Dhumal, D., et al. Dynamic self-assembling supramolecular dendrimer nanosystems as potent antibacterial candidates against drug-resistant bacteria and biofilms. Nanoscale 14, 9286\u20139296 (2022).","journal-title":"Nanoscale"},{"key":"19248_CR77","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jconrel.2018.03.002","volume":"282","author":"L Mart\u00ednez-Jothar","year":"2018","unstructured":"Mart\u00ednez-Jothar, L., et al. Insights into maleimide-thiol conjugation chemistry: conditions for efficient surface functionalization of nanoparticles for receptor targeting. Journal of Controlled Release 282, 101\u2013109 (2018).","journal-title":"Journal of Controlled Release"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19248-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19248-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19248-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:03:30Z","timestamp":1760094210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19248-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19248"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19248-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Blood used in this study was purchased commercially (Krigo s.r.o, Slovakia).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"35482"}}